Docmode Health Technologies intends to raise Rs 6.71 crores. The issue is entirely a fresh issue of 8.5 lakh shares. Docmode Health Technologies Limited provides integrated learning solutions for healthcare professionals and learners worldwide through online and offline learning models.

About Docmode Health Technologies

• DocMode is a platform that provides authoritative, comprehensive and interactive learning programs for Health Professionals – Doctors, Nurses, Allied and Medical Students – across the world.
• This Medical content is created, reviewed and presented by Leading Medical Schools/Universities, Medical Associations and Subject Matter Experts/Key Opinion leaders who are focused to effectively transfer knowledge, as well as communicate and network with each other through Continuing Medical Education (CME) programs and Online Courses.
• Along with learning, DocMode creates an environment where healthcare professionals can interact with the faculty via discussions board attached to each CME and Course as well as take advantage of our performance assessment tools to better their clinical acumen in their daily medical practice.
• Apart from catering to a healthcare professional’s needs in Learning, DocMode has become a platform for various players in the Healthcare space to reach out and engage doctors. With a huge doctor base in a wide range of specialties- from general practitioners to Consultants and to super specialists, this allows doctors to be more involved and improve the healthcare environment across the world.
• DocMode constantly encourages Scientific, Evidence-based practice, Documentation, Inter-professional, Cross-industrial learning, Doctor-Patient interaction, Research Work and Training Skill-based Courses.

Docmode Health Technologies IPO: Financials

Docmode Health Technologies IPO: Salient Points

• Company intends to utilize the Net Proceeds for the following objects

• As on date of this Prospectus, They have 60 certificate programs courses where we have associated with about 40+ Medical Associations and university across the globe.
• Service wise revenue from operations

• Their DocMode SURE service is making good progress. In this they offer network-powered survey, studies & research platform to further evidence-based practice in healthcare. It is platform for practicing & certified professionals in healthcare who can participate or contribute and be nominated for marketing surveys, clinical studies, and research. As on March 31, 2023,they had more than 10,000 (non-unique) registered and verified healthcare professionals who participated in medical research surveys.
• Peers: There are no listed companies in India that engage in a business similar to that of Company.
• Docmode Health Technologies IPO is coming at a PE ratio of 45x (fy23 earnings) and 23x (fy24 annualized earnings).
• I may apply inDocmode Health Technologies IPO. It has shown good growth, is valued reasonably though there seems to be some pressure on its margins and this moment there appears to be little fancy for the scrip.
• Fedex Securities is the lead manager with mixed record so far. Past issues handled by them include IBL Finance Limited, KK Shah Hospitals Limited, Committed Cargo Care Limited, Kundan Edifice Limited, Pramara Promotions Limited, Yasons Chemex Care Limited, Pattech Fitwell Tube Components Limited, Lead Reclaim and Rubber Products Limited, Tapi Fruit Processing Ltd, Virtuoso Optoelectronics Limited, Kesar India Limited.
• Rikhav Securities is the market maker.They have been market maker in IPOs like Graphisads, , Kontor Space, , Unihealth Consultancy IPOUnihealth Consultancy, Mono Pharmacare, Bondada Engineering, Shoora Designs, Sangani Hospitals, Zeal Global Services, Service Care, Aatmaj Healthcare, Spectrum Talent Management, Sahana System, Anlon Technology, MOS Utility, Homesfy Realty etc.
• GMP as heard on Social Media may be around Rs. 25.
• Standard disclaimer: I am not a SEBI registered analyst and above analysis is for educational purpose only. Iam a postgraduate in engineering & Management . I have in the past cleared some exams like NISM-Series-V-A: Mutual Fund Distributors Certification, NISM-Series-X-A: Investment Adviser (Level 1) Certification and NISM-Series-X-B: Investment Adviser (Level 2) Examination. This post is my view on the subject matter and is only academic and exploratory in nature. It is not meant to influence investment decisions of investors. I may have bias/vested interest in covered Stock/Mutual Funds/NCD etc. due to my own investment or leaning. Further my understanding of the areas on which I write may be imperfect or incomplete and data could be wrong due to limited time and resources at my disposal. Do check the data from company’s RHP and exchanges before making any decision. Please do your own due diligence as stock market/MF investments have high degree of inherent risk.